Knowledge

User talk:MuzeMarc

Source 📝

162: 183:
located above the edit window. This will automatically insert a signature with your username or IP address and the time you posted the comment. This information is useful because other editors will be able to tell who said what, and when. Thank you.
131:
article, and I'm sure you can help out with making these changes. However, I encourage you to refrain from deleting information or making substantial changes without discussing the proposed changes first, as instructed at the top of the
136:. You can also place a "citation needed" tag on any statements you feel need additional sources by using two '{' and '}' symbols around 'cn' (for "citation needed"). Please also see the 180: 179: 26: 47: 145: 116: 97: 52: 43: 62: 56: 141: 112: 93: 33: 22: 220:. Your childish accusations mean nothing to me or other editors, only how to make a good article. Try 77: 69: 170: 73: 166: 140:
about sources for medicine-related articles, and let me know if you have any questions. Thank you.
85: 38: 29:. I hope you like the place and decide to stay. Here are some pages that you might find helpful: 84:(~~~~); this will automatically insert your username and the date. If you need help, check out 225: 189: 209: 137: 111:
about your proposed changes to the HIV article. Looking forward to your thoughts. Cheers.
213: 217: 185: 177:( ~~~~ ) at the end of your comment. You could also click on the signature button 88:, ask me on my talk page, or ask your question on this page and then place 221: 133: 239: 193: 149: 120: 101: 224:
if you think you've got something important to add to the article.
174: 81: 199: 128: 127:
MuzeMarc, there are many improvements that can be made to the
169:
and Knowledge pages that have open discussion, you should
165:
Hello. In case you didn't know, when you add content to
205: 108: 8: 68:I hope you enjoy editing here and being a 92:before the question. Again, welcome! 7: 14: 178: 160: 53:How to create your first article 208:is irrelevant. Please review 1: 34:The five pillars of Knowledge 25:to Knowledge! Thank you for 216:. And you should stop the 107:Hi, I started a discussion 255: 194:02:16, 10 March 2011 (UTC) 150:01:55, 10 March 2011 (UTC) 240:04:53, 27 June 2011 (UTC) 121:22:36, 9 March 2011 (UTC) 102:22:26, 9 March 2011 (UTC) 48:How to develop articles 21:Hello, MuzeMarc, and 86:Knowledge:Questions 142:Keepcalmandcarryon 113:Keepcalmandcarryon 94:Keepcalmandcarryon 44:How to edit a page 27:your contributions 238: 156:Your recent edits 76:your messages on 246: 237: 235: 230: 218:personal attacks 182: 164: 163: 91: 78:discussion pages 254: 253: 249: 248: 247: 245: 244: 243: 231: 226: 203: 173:by typing four 171:sign your posts 161: 158: 89: 63:Manual of Style 12: 11: 5: 252: 250: 202: 197: 157: 154: 153: 152: 124: 123: 66: 65: 60: 57:Article Wizard 50: 41: 36: 13: 10: 9: 6: 4: 3: 2: 251: 242: 241: 236: 234: 229: 223: 219: 215: 211: 207: 201: 198: 196: 195: 191: 187: 181: 176: 172: 168: 155: 151: 147: 143: 139: 135: 130: 126: 125: 122: 118: 114: 110: 106: 105: 104: 103: 99: 95: 87: 83: 79: 75: 71: 64: 61: 58: 54: 51: 49: 45: 42: 40: 37: 35: 32: 31: 30: 28: 24: 19: 18: 232: 227: 206:Your opinion 204: 159: 67: 59:if you wish) 20: 16: 15: 90:{{help me}} 80:using four 55:(using the 167:talk pages 138:guidelines 70:Wikipedian 134:talk page 72:! Please 222:Talk:HIV 210:WP:UNDUE 39:Tutorial 17:Welcome! 214:WP:NPOV 186:SineBot 23:welcome 233:Marlin 228:Orange 175:tildes 82:tildes 212:and 190:talk 146:talk 117:talk 109:here 98:talk 74:sign 46:and 200:HIV 129:HIV 192:) 184:-- 148:) 119:) 100:) 188:( 144:( 115:( 96:(

Index

welcome
your contributions
The five pillars of Knowledge
Tutorial
How to edit a page
How to develop articles
How to create your first article
Article Wizard
Manual of Style
Wikipedian
sign
discussion pages
tildes
Knowledge:Questions
Keepcalmandcarryon
talk
22:26, 9 March 2011 (UTC)
here
Keepcalmandcarryon
talk
22:36, 9 March 2011 (UTC)
HIV
talk page
guidelines
Keepcalmandcarryon
talk
01:55, 10 March 2011 (UTC)
talk pages
sign your posts
tildes

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.